A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2

J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.03.046. Epub 2020 Apr 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Betacoronavirus / drug effects*
  • Binding Sites
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections / drug therapy
  • Humans
  • Integrins / therapeutic use*
  • Pandemics
  • Pneumonia, Viral / drug therapy
  • Receptors, Immunologic / drug effects
  • Receptors, Peptide / drug effects
  • Receptors, Virus / drug effects*
  • SARS-CoV-2
  • Severe Acute Respiratory Syndrome / drug therapy
  • Severe acute respiratory syndrome-related coronavirus / drug effects
  • Spike Glycoprotein, Coronavirus / drug effects*
  • Virus Internalization / drug effects

Substances

  • Integrins
  • Receptors, Immunologic
  • Receptors, Peptide
  • Receptors, Virus
  • Spike Glycoprotein, Coronavirus
  • arginyl-glycyl-aspartic acid directed cell adhesion receptor
  • spike protein, SARS-CoV-2